Skip to content

In the BioHarmony Drug Report Database

Edotreotide

Ga-68-DOTATOC, SomaKit TOC (edotreotide) is a small molecule pharmaceutical. Edotreotide was first approved as Ga-68-DOTATOC on 2016-12-08. It has been approved in Europe to treat neuroendocrine tumors and radionuclide imaging. It is known to target somatostatin receptor type 2.
Trade Name SomaKit TOC
Common Name Edotreotide
Indication neuroendocrine tumors, radionuclide imaging
Drug Class Peptides: inhibition of growth hormone release
Edotreotide
Get full access now